Home » Newsletters » BioWorld Science

BioWorld Science

July 5, 2007

View Archived Issues

New therapeutic agents for cancer covered in recent patent literature

Trodusquemine reduces weight, adiposity and improves plasma insulin and leptin in DIO mice

Recent patents disclose novel antiinfective agents

Recent clinical results with new insulin formulations

Mitochondrial voltage-dependent anion channels appear as new targets in cancer therapy

Recent patents disclose novel agents for obesity and disorders of lipoprotein metabolism

Algeta initiates clinical dosimetry study with Alpharadin in HRPC patients

Surface Logix evaluates long-acting PDE-5 inhibitors for cardiovascular indications

The Medicines Company reacquires Angiox in Europe

MerLion begins phase I clinical study of antibiotic friulimicin B

Update on Advanced Life Sciences' phase III trial of cethromycin

Positive phase II results for Anesiva's drug candidate Adlea

Maxygen begins phase IIa trial of MAXY-G34 for breast cancer

Pan-PPAR agonist may be beneficial in accelerated atherosclerosis

Studies show favorable pharmacokinetics, reduced costs with CERA

Snapshots of acute and prophylactic treatments for migraine

Clinical trials with natural products in psoriasis

Clinical trials on rhGH formulations reported at ESPE

CYT003-QbG10 shows no treatment effect in atopic dermatitis

Wyeth assumes European marketing and distribution rights for BeneFIX

NICE recommends Tysabri in highly active relapsing remitting MS

Daivobet Scalp gel filed for scalp psoriasis in U.S. and E.U.

EpiCept accelerates clinical trials of EPC-2407 in cancer

Medtronic's ENDEAVOR IV clinical trial meets primary endpoint

Regulatory guidance on pivotal program for Chronocort

Azur licenses FazaClo rights from Avanir

Japanese priority review for Plavix sNDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...